Chronic inflammation and aberrant activity of STAT3 cell signaling pathway play important roles in hepatocarcinogenesis, for all these reasons, STAT3 represents an attractive target in HCC therapy. The gene discussed is STAT3; the disease is hepatocellular carcinoma.